MarketCapTrends
PSTV
Plus Therapeutics Inc (PSTV)
NASDAQ · Healthcare

Plus Therapeutics Inc Shareholder Equity 2009–2025

Plus Therapeutics Inc annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Plus Therapeutics Inc shareholder equity for the quarter ending December 31, 2025 were 4.0M, a 144.65% decrease year-over-year.
  • Plus Therapeutics Inc shareholder equity for 2025 were 4.0M, a 144.65% decrease from 2024.
  • Plus Therapeutics Inc shareholder equity for 2024 were -8.9M, a 563.87% increase from 2023.
  • Plus Therapeutics Inc shareholder equity for 2023 were -1.3M, a 125.80% decrease from 2018.
  • Plus Therapeutics Inc shareholder equity for 2018 were 5.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Plus Therapeutics Inc Annual Shareholder Equity (Millions of US $)
2025$4
2024$-9
2023$-1
2018$5
2017$13
2016$11
2015$12
2014$-6
2013$3
2012$6
2011$10
2010$23
Plus Therapeutics Inc Quarterly Shareholder Equity (Millions of US $)
2025-12-31$4
2024-12-31$-9
2023-12-31$-1
2018-12-31$5
2017-12-31$13
2016-12-31$11
2015-12-31$12
2014-12-31$-6
2013-12-31$3
2012-12-31$6
2011-12-31$10
2010-12-31$23

Plus Therapeutics Inc Shareholder Equity — FAQ

Plus Therapeutics Inc (PSTV) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see PSTV's shareholder equity history?

The chart and table above show Plus Therapeutics Inc's shareholder equity by year and by quarter, including the growth rate.